Tyrosine News
Tyrosine currently has 0 news articles, with 9 predicted indications.
This page combines the AI-predicted indications for Tyrosine with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: he TxGNN model ranks **cauda equina syndrome** as its top prediction, but **no clinical trials and no publications** support this direction (Evidence Level L5, model prediction only).
- Evidence level: L5
- Predicted indications (9):
- Neurogenic bladder (obsolete term) | 99.55% | Speculative link via catecholamine control of the bladder. No evidence, and the disease term is ambiguous. (99.0%)
- Angle-closure glaucoma | 99.54% | No direct mechanism. Retrieved papers are association or descriptive studies only. (99.0%)
- Hyperthyroidism | 99.51% | Tyrosine is a thyroid hormone substrate, so benefit is mechanistically doubtful and it may be counterproductive. (99.0%)
- Postural orthostatic tachycardia syndrome | 99.46% | Catecholamine precursor, which is plausible, but the only paper is a case report using a tyrosine hydroxylase inhibitor (opposite pharmacology). Evidence Level L4. (99.0%)
- Hyperthyroxinemia | 99.46% | Tyrosine is a thyroxine precursor, so lowering thyroxine is unlikely. (99.0%)
- Resistance to thyroid hormone (TRβ mutation) | 99.40% | Receptor-level defect that a hormone substrate would not correct. (99.0%)
- Aqueous misdirection | 99.35% | No plausible mechanism. (99.0%)
- Traumatic glaucoma | 99.35% | No direct mechanism. (99.0%)
- Neovascular glaucoma | 99.32% | No direct mechanism. Standard care is anti-VEGF therapy, laser and surgery. (99.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.